229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Analyze DCF forecasts for the company and compare them with competitors.
573.95B
Revenue has increased from the previous period.
10.07%
Revenue growth rate is unchanged from the previous period.
188.49B
EBITDA has increased from the previous period.
32.84%
EBITDA margin is unchanged from the previous period.
170.28B
EBIT has increased from the previous period.
29.67%
EBIT margin is unchanged from the previous period.
18.21B
Depreciation has increased from the previous period.
109.31B
Total cash has increased from the previous period.
19.05%
Cash percentage is unchanged from the previous period.
87.27B
Receivables have increased from the previous period.
15.20%
Receivables percentage is unchanged from the previous period.
9.24B
Inventories have increased from the previous period.
1.61%
Inventory percentage is unchanged from the previous period.
92.53B
Accounts payable has increased from the previous period.
16.12%
Payables percentage is unchanged from the previous period.
-15.71B
Capital expenditure has increased from the previous period.
-2.74%
CapEx percentage is unchanged from the previous period.
8.68%
WACC is unchanged from the previous period.
8.86%
Cost of equity is unchanged from the previous period.
3.63%
Cost of debt is unchanged from the previous period.
1.11
Beta is unchanged from the previous period.
15.41B
Diluted shares outstanding is unchanged from the previous period.
119.06B
Total debt is unchanged from the previous period.
3.61T
Total equity is unchanged from the previous period.
3.73T
Total capital is unchanged from the previous period.
3.20%
Debt weighting is unchanged from the previous period.
96.80%
Equity weighting is unchanged from the previous period.
142.10B
EBIAT has increased from the previous period.
144.24B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
3.53T
Terminal value is unchanged from the previous period.
2.84T
Enterprise value is unchanged from the previous period.
89.12B
Net debt is unchanged from the previous period.
2.75T
Equity value is unchanged from the previous period.
178.56
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
415.00B
The estimated revenue has increased from the previous period.
136.29B
The estimated EBITDA has increased from the previous period.
7.38
The estimated EPS has increased from the previous period.
113.17B
The estimated net income has increased from the previous period.
123.12B
The estimated EBIT has increased from the previous period.
27.23B
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$228.20
Analysts expect the stock price to decrease by 2.51%.
Buy
Positive consensus among analysts.
